CSF2 and seasonal allergic rhinitis: Taken together, the reduction in GM-CSF and IL8 observed during use of CCSNOP may indicate that CCSNOP has a direct effect on the human immune system and that these effects may result in reduced symptoms in people with pollen allergies.